Latest News
Advancements in Pancreatic Cancer Treatment: Biotech Innovations and Rising Optimism
USA News Group – According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic cancer increased by 1% from the previous year to 12%. The increase has generated more...
Is the Worst Over for Illumina Stock?
There's reason to believe that the future is starting to look better.
Cathie Wood's Buying These 3 Stocks Hand Over Fist
A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.
What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.56%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.11%. Stocks on Tuesday settled mixed. The broader market was...
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.08%. Stock indexes this morning are mixed. The broader market...
Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has...
Illumina To Webcast Upcoming Investor Conference
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Morgan Stanley 21st...
Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen.
Its core revenue won't grow, and that's not even its biggest problem at the moment.
Illumina expands genomics capabilities in India with opening of Solutions Center
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of a new office and...
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Illumina's future is looking a bit dim at the moment.
Why Shares of SomaLogic Are Up Tuesday
The company showed strong revenue growth in the second quarter.
Illumina To Webcast Upcoming Investor Conference
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its vice president of investor relations will be speaking at the following investor...
AppLovin, Wynn Resorts rise; Tapestry, Plug Power fall, Thursday, 8/10/2023
Stocks that traded heavily or had substantial price changes Thursday: AppLovin, Wynn Resorts rise; Tapestry, Plug Power fall
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.16%. Today’s benign U.S. July CPI report bolstered the outlook...
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.54%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.80%. Stock indexes this morning are moderately higher after the weaker-than-expected U.S. Jul CPI report bolstered the outlook for the Fed to pause its interest rate...
Dr. Steven Barnard Appointed Chief Technology Officer
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Dr. Steven Barnard, Illumina's...
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2023
Revenue of $1.18 billion for Q2 2023, up 1% from Q2 2022 (up 3% on a constant currency basis) and up 8% from Q1 2023 Shipped 109 NovaSeq X instruments in Q2...
Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of...
Illumina to Announce Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
/PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the second quarter 2023 following the close of market on Wednesday,...
The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC,...
Illumina DRAGEN™ 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the latest version...
Medical-sector stocks Waters, Agilent, and Illumina appear to be trading at low valuations relative to their future growth prospects, according to analysts.
Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear?
Things aren't looking up just yet.
Illumina CEO Steps Down; Grail Soap Opera Continues
And we interview Anjay Nagpal, host of the podcast "Brokers, Bagmen, and Moles."
TriNet, Nasdaq fall; Ballard Power, Chinook Therapeutics rise, Monday, 6/12/2023
Stocks that traded heavily or had substantial price changes Tuesday: TriNet, Nasdaq fall; Ballard Power, Chinook Therapeutics rise